Efficacy and Safety of Soy Protein Based Formula in Atopic Dermatitis

  • Yeom, Kkot-Bo-Ra (Department of Dermatology, Seoul National University College of Medicine) ;
  • Kim, Kyu-Han (Department of Dermatology, Seoul National University College of Medicine)
  • Received : 2011.08.18
  • Accepted : 2011.09.08
  • Published : 2011.09.30


Soy protein based formula (SPF) has been developed for infants who are at a high risk for atopic dermatitis (AD) and cow's milk protein allergy (CMA). We performed this study to evaluate the therapeutic efficacy and safety of SPF compared to conventional hydrolyzed cow's milk formula (hCMF) in the feeding of infants with AD and CMA. 38 infants (12 to 24 months of age) diagnosed with CMA and AD were randomized to receive either SPF or hCMF for 12 weeks. Follow-up was conducted at 4, 8 and 12 weeks. Growth parameters of the infants were evaluated during each visit. Clinical evaluations, including AD severity scores, pruritus, specific immunoglobulin E (IgE) (cow's milk protein and soy protein) levels of peripheral blood, were made at enrollment and week 12. Analysis was performed on the 32 infants (SPF: n=16, hCMF: n=16) who completed the 12-week intervention. Eczema area and severity index (EASI) scores, a measure of the severity of AD, and pruritus were significantly reduced after 12 weeks compared to enrollment in the both groups; however, the median changes for EASI scores and pruritus were not statistically different between the two groups. The growth parameters did not differ significantly between both groups at any assessed time point. This study suggests that SPF could be useful in decreasing the severity of AD without affecting infant growth status. Therefore SPF could provide an adequate and safe alternative to hCMF in treating infants with AD and CMA during the first 12 to 24 months of their life.


  1. Moore MM, Rifas-Shiman SL, Rich-Edwards JW, Kleinman KP, Camargo CA Jr, Gold DR, Weiss ST, Gillman MW. 2004. Perinatal predictors of atopic dermatitis occurring in the first six months of life. Pediatrics 113: 468- 474.
  2. Greer FR, Sicherer SH, Burks AW. 2008. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 121: 183-191.
  3. Bieber T. 2008. Atopic dermatitis. N Engl J Med 358: 1483-1494.
  4. Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. 2003. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 49: 1088-1095.
  5. Hahn EL, Bacharier LB. 2005. The atopic march: the pattern of allergic disease development in childhood. Immunol Allergy Clin North Am 25: 231-246.
  6. Burks AW, James JM, Hiegel A, Wilson G, Wheeler JG, Jones SM, Zuerlein N. 1998. Atopic dermatitis and food hypersensitivity reactions. J Pediatr 132: 132-136.
  7. Novembre E, Vierucci A. 2001. Milk allergy/intolerance and atopic dermatitis in infancy and childhood. Allergy 67: 105-108.
  8. Pourpak Z, Farhoudi A, Mahmoudi M, Movahedi M, Ghargozlou M, Kazemnejad A, Eslamnoor B. 2004. The role of cow milk allergy in increasing the severity of atopic dermatitis. Immunol Invest 33: 69-79.
  9. Thygarajan A, Burks AW. 2008. American Academy of Pediatrics recommendations on the effects of early nutritional interventions on the development of atopic disease.Curr Opin Pediatr 20: 698-702.
  10. Reche M, Pascual C, Fiandor A, Polanco I, Rivero-Urgell M, Chifre R, Johnston S, Martin-Esteban M. 2010. The effect of a partially hydrolysed formula based on rice protein in the treatment of infants with cow's milk protein allergy. Pediatr Allergy Immunol 21: 577-585.
  11. Jin YY, Cao RM, Chen J, Kaku Y, Wu J, Cheng Y, Shimizu T, Takase M, Wu SM, Chen TX. 2011. Partially hydrolyzed cow's milk formula has a therapeutic effect on the infants with mild to moderate atopic dermatitis: a randomized, double-blind study. Pediatr Allergy Immunol 4; 10.1111/j.1399-3038.
  12. Hanifin JM, Rajka G. 1980. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 2: 44-47.
  13. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. 2001. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 10: 11-18.
  14. Bhatia J, Greer F. 2008. Use of soy protein-based formulas in infant feeding. Pediatrics 121: 1062-1068.
  15. Businco L, Bruno G, Giampietro PG, Cantani A. 1992. Allergenicity and nutritional adequacy of soy protein formulas. J Pediatr 121: S21-S28.
  16. Merritt RJ, Jenks BH. 2004. Safety of soy-based infant formulas containing isoflavones: the clinical evidence. J Nutr 134: 1220S-1224S.
  17. Agostoni C, Axelsson I, Goulet O, Koletzko B, Michaelsen KF, Puntis J, Rieu D, Rigo J, Shamir R, Szajewska H, Turck D. 2006. Soy protein infant formulae and follow-on formulae: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 42: 352-361.
  18. Mimouni F, Campaigne B, Neylan M, Tsang RC. 1993. Bone mineralization in the first year of life in infants fed human milk, cow-milk formula, or soy-based formula. J Pediatr 122: 348-354.
  19. Cantani A, Ferrara M, Ragno V, Businco L. 1990. Efficacy and safety of a soy-protein-formula for feeding babies with atopic dermatitis and cow's milk hypersensitivity. Riv Eur Sci Med Farmacol 12: 311-318.
  20. Cantani A, Lucenti P. 1997. Natural history of soy allergy and/or intolerance in children, and clinical use of soy-protein formulas. Pediatr Allergy Immunol 8: 59-74.
  21. Businco L, Bruno G, Giampietro PG. 1998. Soy protein for the prevention and treatment of children with cow-milk allergy. Am J Clin Nutr 68: 1447S-1452S.
  22. Host A, Jacobsen HP, Halken S, Holmenlund D. 1995. The natural history of cow's milk protein allergy/intolerance. Eur J Clin Nutr 49: S13-S18.
  23. Zeiger RS, Sampson HA, Bock SA, Burks AW Jr, Harden K, Noone S, Martin D, Leung S, Wilson G. 1999. Soy allergy in infants and children with IgE-associated cow's milk allergy. J Pediatr 134: 614-622.